Glaucoma Treatment - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Medical Care > Glaucoma Treatment - Global Top Players Market Share and Ranking 2025

Glaucoma Treatment - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-09-24
Report Id: 2456201
Industry: Medical Care
Report Page: 96
Chart: 93

PDF Download

Publication Date: 2025-09-24
Report Id: 2456201
Industry: Medical Care
Report Page: 96
Chart: 93

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Glaucoma Treatment Definition
1.2 Global Glaucoma Treatment Market Size and Forecast
1.3 China Glaucoma Treatment Market Size and Forecast
1.4 Share of China Glaucoma Treatment Market with Respect to the Global Market
1.5 Glaucoma Treatment Market Size: China VS Global Growth Rate, 2020-2031
1.6 Glaucoma Treatment Market Dynamics
1.6.1 Glaucoma Treatment Market Drivers
1.6.2 Glaucoma Treatment Market Restraints
1.6.3 Glaucoma Treatment Industry Trends
1.6.4 Glaucoma Treatment Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Glaucoma Treatment, Global Market Share by Company, 2020-2025
2.2 Global Glaucoma Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Glaucoma Treatment Concentration Ratio
2.4 Global Glaucoma Treatment Mergers & Acquisitions, Expansion Plans
2.5 Global Glaucoma Treatment Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Glaucoma Treatment, China Market Share by Company, 2020-2025
3.2 China Glaucoma Treatment Glaucoma Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Glaucoma Treatment Industry Chain
4.2 Glaucoma Treatment Upstream Analysis
4.2.1 Glaucoma Treatment Core Raw Materials
4.2.2 Main Manufacturers of Glaucoma Treatment Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Glaucoma Treatment Production Mode
4.6 Glaucoma Treatment Procurement Model
4.7 Glaucoma Treatment Industry Sales Model and Sales Channels
4.7.1 Glaucoma Treatment Sales Model
4.7.2 Glaucoma Treatment Typical Distributors

5 Sights by Product
5.1 Glaucoma Treatment Classification by Product
5.1.1 Prostaglandin Analogs (PGAs)
5.1.2 Beta Blocker
5.1.3 Alpha Agonist
5.1.4 Others
5.2 by Product, Global Glaucoma Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Product, Global Glaucoma Treatment Consumption Value, 2020-2031

6 Sights by Application
6.1 Glaucoma Treatment Segment by Application
6.1.1 Clinic
6.1.2 Pharmacy
6.1.3 Other
6.2 by Application, Global Glaucoma Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Glaucoma Treatment Consumption Value, 2020-2031

7 Sales Sights by Region
7.1 By Region, Global Glaucoma Treatment Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Glaucoma Treatment Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Glaucoma Treatment Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Glaucoma Treatment Market Size Market Share
7.4 Europe
7.4.1 Europe Glaucoma Treatment Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Glaucoma Treatment Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Glaucoma Treatment Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Glaucoma Treatment Market Size Market Share
7.6 South America
7.6.1 South AmericaGlaucoma Treatment Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Glaucoma Treatment Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Glaucoma Treatment Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Glaucoma Treatment Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Glaucoma Treatment Market Size, 2020-2031
8.3.2 by Product, United States Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Glaucoma Treatment Market Size, 2020-2031
8.4.2 by Product, Europe Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Glaucoma Treatment Market Size, 2020-2031
8.5.2 by Product, China Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Glaucoma Treatment Market Size, 2020-2031
8.6.2 by Product, Japan Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Glaucoma Treatment Market Size, 2020-2031
8.7.2 by Product, South Korea Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Glaucoma Treatment Market Size, 2020-2031
8.8.2 by Product, Southeast Asia Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Glaucoma Treatment Market Size, 2020-2031
8.9.2 by Product, India Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Glaucoma Treatment Market Size, 2020-2031
8.10.2 by Product, Middle East & Africa Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Glaucoma Treatment Consumption Value Market Share, 2024 VS 2031

9 Company Profile
9.1 Novartis
9.1.1 Novartis Company Information, Head Office, Market Area, and Industry Position
9.1.2 Novartis Company Profile and Main Business
9.1.3 Novartis Glaucoma Treatment Models, Specifications, and Application
9.1.4 Novartis Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.1.5 Novartis Recent Developments
9.2 AbbVie
9.2.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
9.2.2 AbbVie Company Profile and Main Business
9.2.3 AbbVie Glaucoma Treatment Models, Specifications, and Application
9.2.4 AbbVie Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.2.5 AbbVie Recent Developments
9.3 Pfizer
9.3.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
9.3.2 Pfizer Company Profile and Main Business
9.3.3 Pfizer Glaucoma Treatment Models, Specifications, and Application
9.3.4 Pfizer Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.3.5 Pfizer Recent Developments
9.4 Akorn
9.4.1 Akorn Company Information, Head Office, Market Area, and Industry Position
9.4.2 Akorn Company Profile and Main Business
9.4.3 Akorn Glaucoma Treatment Models, Specifications, and Application
9.4.4 Akorn Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.4.5 Akorn Recent Developments
9.5 Teva
9.5.1 Teva Company Information, Head Office, Market Area, and Industry Position
9.5.2 Teva Company Profile and Main Business
9.5.3 Teva Glaucoma Treatment Models, Specifications, and Application
9.5.4 Teva Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.5.5 Teva Recent Developments
9.6 Bausch & Lomb
9.6.1 Bausch & Lomb Company Information, Head Office, Market Area, and Industry Position
9.6.2 Bausch & Lomb Company Profile and Main Business
9.6.3 Bausch & Lomb Glaucoma Treatment Models, Specifications, and Application
9.6.4 Bausch & Lomb Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.6.5 Bausch & Lomb Recent Developments
9.7 Otsuka Pharmaceutical
9.7.1 Otsuka Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.7.2 Otsuka Pharmaceutical Company Profile and Main Business
9.7.3 Otsuka Pharmaceutical Glaucoma Treatment Models, Specifications, and Application
9.7.4 Otsuka Pharmaceutical Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.7.5 Otsuka Pharmaceutical Recent Developments
9.8 Santen
9.8.1 Santen Company Information, Head Office, Market Area, and Industry Position
9.8.2 Santen Company Profile and Main Business
9.8.3 Santen Glaucoma Treatment Models, Specifications, and Application
9.8.4 Santen Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.8.5 Santen Recent Developments
9.9 Lunan Pharma
9.9.1 Lunan Pharma Company Information, Head Office, Market Area, and Industry Position
9.9.2 Lunan Pharma Company Profile and Main Business
9.9.3 Lunan Pharma Glaucoma Treatment Models, Specifications, and Application
9.9.4 Lunan Pharma Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.9.5 Lunan Pharma Recent Developments
9.10 Zizhu Pharma
9.10.1 Zizhu Pharma Company Information, Head Office, Market Area, and Industry Position
9.10.2 Zizhu Pharma Company Profile and Main Business
9.10.3 Zizhu Pharma Glaucoma Treatment Models, Specifications, and Application
9.10.4 Zizhu Pharma Glaucoma Treatment Revenue and Gross Margin, 2020-2025
9.10.5 Zizhu Pharma Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Glaucoma Treatment should grow from US$ 6888 million in 2024 to US$ 9117 million by 2031, with a CAGR of 4.0% for the period of 2025-2031.

Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.

Glaucoma Treatment

According to YH Research, the global market for Glaucoma Treatment should grow from US$ 6888 million in 2024 to US$ 9117 million by 2031, with a CAGR of 4.0% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The accumulated burden of aging populations and chronic ophthalmic conditions is driving persistent demand for accessible IOP lowering and neuroprotective therapies. Clinical advances and commercialization roadmaps in sustained-release pharmacotherapies, minimally invasive surgical options and non-pharmacologic devices (such as wearable IOP management systems and pressure-adjusting pumps) have been explicitly incorporated into the medium- and long-term strategies of major listed players, expanding product categories and enabling geographic penetration. Robust reimbursement and regulatory frameworks in developed markets create premium opportunities for high-quality innovations, while improvements in primary eye care in emerging markets offer expansion levers. Companies that can translate R&D into compliant, scalable products and build differentiated channel and service models stand to amplify commercial value.

Key challenges include onerous regulatory and clinical evidence requirements, the need to demonstrate durable long-term safety and efficacy, and the difficulty of translating trial results into real-world adherence and outcomes. Novel devices and delivery systems often require prolonged clinical programs and intensive regulatory dialogue, which slows commercialization and raises costs; supply chain robustness, material sourcing and advanced manufacturing capability are critical risks for scale-up. Regulators place particular emphasis on patient experience and long-term surveillance in older populations; post-market issues can lead to high-visibility compliance and reputational risks.

End-user demand is shifting from pure efficacy toward a complete treatment experience: patients and providers prioritize dosing convenience, lowered long-term burden, comorbidity management and total cost of care. Hospitals and specialty clinics are receptive to reusable surgical adjuncts, complementary procedural products and service-linked solutions integrated with clinical pathways; home care and remote monitoring trends push manufacturers to design for usability and digital connectivity. Traditional distribution and institutional procurement remain significant, but direct-to-patient digital channels and retail are growing, elevating the importance of brand and end-user education.

This report studies and analyses global Glaucoma Treatment status and future trends, to help determine the Glaucoma Treatment market size of the total market opportunity by Product, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Glaucoma Treatment, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Glaucoma Treatment market size, history data 2020-2025, and forecast data 2026 -2031, (US$ million)
(2) Global Glaucoma Treatment by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(3) China Glaucoma Treatment by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(4) Global Glaucoma Treatment key consuming regions, consumption value and demand structure
(5) Glaucoma Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Novartis
AbbVie
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma

Market segment by Product, covers
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Others

Market segment by Application, can be divided into
Clinic
Pharmacy
Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Glaucoma Treatment product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Glaucoma Treatment market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 3: China Glaucoma Treatment market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 4: Glaucoma Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Product, consumption value, percent & CAGR, 2020-2031
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2020-2031
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions